Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2023 06:48 ET | Source: Research and Markets

Global Hair Extension Market Report 2023-2030: Locks & Bonds, Klix Hair Inc., and Balmain Hair Group BV Among Top Players in the Booming Hair Extension Market

Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Hair Extension Market Forecast to 2030 - Global Analysis by Product Type, Source, and Distribution Channel" report has been added to ...
December 13, 2022 06:13 ET | Source: Research and Markets

$1.78+ Billion Worldwide Protein Shampoo Industry to 2031 - Increasing Prevalence of Hair and Scalp-Related Diseases is Expected to Propel Growth

Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Protein Shampoo Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
October 25, 2022 15:45 ET | Source: Straits Research

Keratin Market Size is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 6%: Straits Research

New York, United States, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Keratin is a biochemical that is used in developing and producing personal care products, specifically for nails, skin, and hair. The...
June 16, 2022 06:13 ET | Source: Research and Markets

Worldwide Hair Care Products Industry to 2028 - Featuring Procter Gamble, Avon Products and Revlon Among Others

Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Hair Care Products Market, by Type, by Distribution Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been...
December 18, 2018 08:00 ET | Source: Palvella Therapeutics

Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

Wayne, PA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for...
November 12, 2018 08:00 ET | Source: Palvella Therapeutics

Palvella Therapeutics Announces FDA Fast Track Designation for PTX-022 for Treatment of Pachyonychia Congenita

Wayne, PA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for...